- Home
- SGLY vs TSBX Comparison
SGLY vs TSBX Comparison
Compare SGLY & TSBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGLY
- TSBX
- Stock Information
- Founded
- SGLY 2001
- TSBX 2015
- Country
- SGLY United States
- TSBX United States
- Employees
- SGLY N/A
- TSBX N/A
- Industry
- SGLY
- TSBX
- Sector
- SGLY
- TSBX
- Exchange
- SGLY Nasdaq
- TSBX Nasdaq
- Market Cap
- SGLY 5.8M
- TSBX 11.4M
- IPO Year
- SGLY 2008
- TSBX 2023
- Fundamental
- Price
- SGLY $1.55
- TSBX $0.48
- Analyst Decision
- SGLY
- TSBX Buy
- Analyst Count
- SGLY 0
- TSBX 3
- Target Price
- SGLY N/A
- TSBX $4.75
- AVG Volume (30 Days)
- SGLY 14.2K
- TSBX 93.1K
- Earning Date
- SGLY 11-14-2024
- TSBX 11-12-2024
- Dividend Yield
- SGLY N/A
- TSBX N/A
- EPS Growth
- SGLY N/A
- TSBX N/A
- EPS
- SGLY N/A
- TSBX N/A
- Revenue
- SGLY $2,742,157.00
- TSBX N/A
- Revenue This Year
- SGLY N/A
- TSBX N/A
- Revenue Next Year
- SGLY N/A
- TSBX N/A
- P/E Ratio
- SGLY N/A
- TSBX N/A
- Revenue Growth
- SGLY N/A
- TSBX N/A
- 52 Week Low
- SGLY $1.27
- TSBX $0.40
- 52 Week High
- SGLY $7.65
- TSBX $5.75
- Technical
- Relative Strength Index (RSI)
- SGLY 43.10
- TSBX 39.58
- Support Level
- SGLY $1.58
- TSBX $0.48
- Resistance Level
- SGLY $1.71
- TSBX $0.51
- Average True Range (ATR)
- SGLY 0.09
- TSBX 0.05
- MACD
- SGLY -0.00
- TSBX -0.00
- Stochastic Oscillator
- SGLY 35.71
- TSBX 22.22
About SGLY Singularity Future Technology Ltd.
Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.
About TSBX Turnstone Biologics Corp.
Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.